Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E A Lockhart

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
The Journal of Antimicrobial Chemotherapy|December 29, 2020
The impact of anti-mould prophylaxis on Aspergillus PCR blood testing for the diagnosis of invasive aspergillosisM Cruciani, P L White, C Mengoli, et al.
The Journal of Infection|August 7, 2023
European candidaemia is characterised by notable differential epidemiology and susceptibility pattern: Results from the ECMM Candida III studyMaiken Cavling Arendrup, Sevtap Arikan-Akdagli, Karin Meinike Jørgensen, et al.
Open Forum Infectious Diseases|April 1, 2026
Clinical Characteristics, Management and Outcomes of Nonintensive Care Unit Candidemia: Subanalysis of the ECMM <i>Candida</i> III Multinational European Observational Cohort StudyStella Wolfgruber, Carolina Garcia-Vidal, Sarah Sedik, et al.
The Lancet. Infectious Diseases|May 31, 2023
Guideline adherence and survival of patients with candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort studyMartin Hoenigl, Jon Salmanton-García, Matthias Egger, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
The Journal of Antimicrobial Chemotherapy|December 29, 2020
The impact of anti-mould prophylaxis on Aspergillus PCR blood testing for the diagnosis of invasive aspergillosisM Cruciani, P L White, C Mengoli, et al.
The Journal of Infection|August 7, 2023
European candidaemia is characterised by notable differential epidemiology and susceptibility pattern: Results from the ECMM Candida III studyMaiken Cavling Arendrup, Sevtap Arikan-Akdagli, Karin Meinike Jørgensen, et al.
Open Forum Infectious Diseases|April 1, 2026
Clinical Characteristics, Management and Outcomes of Nonintensive Care Unit Candidemia: Subanalysis of the ECMM <i>Candida</i> III Multinational European Observational Cohort StudyStella Wolfgruber, Carolina Garcia-Vidal, Sarah Sedik, et al.
The Lancet. Infectious Diseases|May 31, 2023
Guideline adherence and survival of patients with candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort studyMartin Hoenigl, Jon Salmanton-García, Matthias Egger, et al.
Pageof 3